Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)
NCT04838444
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
363
Enrollment
INDUSTRY
Sponsor class
Conditions
Chikungunya Virus Infection
Interventions
BIOLOGICAL:
VLA1553
Sponsor
Valneva Austria GmbH